02/14/2025
9:21 AM | Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025
8:59 AM | Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
01/02/2025
7:02 PM | Athira Pharma (Subject)
CHURCH KEVIN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
7:04 PM | Athira Pharma (Subject)
Worthington Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
7:05 PM | Athira Pharma (Subject)
Litton Mark James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2025
7:06 PM | Athira Pharma (Subject)
San Martin Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
12:15 PM | Athira Pharma (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
10/31/2024
3:16 PM | Athira Pharma (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
10/28/2024
11:15 PM | Athira Pharma (Filer)
| Form EFFECT | |
10/21/2024
5:24 AM | Athira Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/03/2024
8:50 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4/A | |
Get the Latest News and Ratings for ATHA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Athira Pharma and its competitors with MarketBeat's FREE daily newsletter. |
10/03/2024
6:07 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:08 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:10 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:13 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:17 PM | Athira Pharma (Issuer)
Renninger Robert (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
6:05 PM | Athira Pharma (Issuer)
Renninger Robert (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/17/2024
8:00 AM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
6:47 PM | Athira Pharma (Issuer)
Litton Mark James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:48 PM | Athira Pharma (Issuer)
Worthington Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:49 PM | Athira Pharma (Issuer)
CHURCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:50 PM | Athira Pharma (Issuer)
Lenington Rachel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:51 PM | Athira Pharma (Issuer)
Gengos Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:53 PM | Athira Pharma (Subject)
Litton Mark James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:15 PM | Athira Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024
6:21 PM | Athira Pharma (Issuer)
Romano Kelly A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:05 PM | Athira Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
5:54 PM | Athira Pharma (Issuer)
FLUKE JOHN M JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:55 PM | Athira Pharma (Issuer)
PICKERING GRANT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:56 PM | Athira Pharma (Issuer)
Panzara Michael A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
5:58 PM | Athira Pharma (Issuer)
Kosacz Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:00 PM | Athira Pharma (Issuer)
JOHNSON JAMES A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:01 PM | Athira Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:03 PM | Athira Pharma (Issuer)
Romano Kelly A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:34 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/16/2024
3:37 PM | Athira Pharma (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
7:32 AM | Athira Pharma (Filer)
| Form DEF 14A | |
04/09/2024
7:34 AM | Athira Pharma (Filer)
| Form DEFA14A | |
04/09/2024
7:35 AM | Athira Pharma (Filer)
| Form ARS | |
03/28/2024
7:47 AM | Athira Pharma (Filer)
| Form PRE 14A | |
02/22/2024
3:34 PM | Athira Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad) Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000.
Should you sit on the sideline while this is happening? That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y |
02/22/2024
3:15 PM | Athira Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Free ATHA Stock Alerts